Show Summary Details
Page of

Breast symptoms in women who are not breastfeeding 

Breast symptoms in women who are not breastfeeding

Chapter:
Breast symptoms in women who are not breastfeeding
Author(s):

Murray Enkin

, Marc J. N. C. Keirse

, James Neilson

, Caroline Crowther

, Lelia Duley

, Ellen Hodnett

, and Justus Hofmeyr

DOI:
10.1093/med/9780192631732.003.0048
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 22 June 2017

The available evidence suggests that physical methods of lactation suppression, such as breast binding, are as effective or more effective than pharmacological methods in the longer term, although they are associated with more pain in the first week after childbirth. Women should be informed of these relative advantages and disadvantages when a method to suppress lactation is chosen. If they decide to use one of the pharmacological approaches, the available evidence suggests that cabergoline should be the drug of choice. Cabergoline and newer drugs that may be developed, should be compared formally with physical methods of suppressing lactation in controlled trials with adequate sample sizes and duration of follow-up. Women’s views of the relative merits and disadvantages of the alternative methods should be an essential element in the evaluation, and more serious attention should be given to documenting the frequency of short- and long-term adverse reactions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.